

Select an energy label expert (“erkend deskundige”)ġ.What is the role of an energy label expert (“erkend deskundige”)?.Overview of all evidence and the complete request for a final energy label.Upload all evidence that is relevant to determine the final energie label of the home.Overview of all characteristics of the home.Are there any special energy saving measures taken for your home that are relevant for the energy label of your home?.Hot water supply (enter data about the hot water generating unit).Heating the house (enter data about the heat generating unit).Insulation value of the floor (enter data for homes built in 1991 and earlier).Insulation value of the roof (enter data for homes built in 1991 and earlier).Insulation value of the facade & walls of your home (enter data for homes built in 1991 and earlier).Type of glasses of the living rooms and bed rooms of your house (complete the data of your home).Five main steps to determine the final energy label of your home.Start at the website “” of the Dutch government.(het energielabel voor woningen aanvraag proces vertaald in het Engels)

#LABEL EXPERT HOW TO#
We herein offer expert guidance based on clinical experience and available case reports on how to identify appropriate candidates for HCL therapy in pregnancy, how to counsel pregnant women with diabetes on the potential risks and benefits of HCL therapy during pregnancy, and how to manage commercially available systems off-label throughout gestation in an assisted HCL approach.Īutomated insulin delivery Hybrid closed-loop therapy Insulin pump therapy Pregestational diabetes Pregnancy care Pregnancy-associated diabetes.Requesting an energy label for your home? Have a look at our step by step overview of how to do this! All screenshots of the complete process to request a final energy label – translated in English and explained: Achievement of strict pregnancy glycemic targets can be difficult, and it is conceivable that selective off-label use of clinically available HCL systems in some women could lead to improved glycemia.

Despite these limitations, many women conceive while using clinically available HCL systems and may be hesitant to cease use during pregnancy. As such, any use of these systems during pregnancy is considered off-label in the United States and would be "assisted" by provider/user techniques. Unfortunately, none of the hybrid closed-loop (HCL) systems that are currently available in the United States have glucose targets that are as aggressive as pregnancy glycemic targets, none have a pregnancy-specific algorithm, and none are approved for use during pregnancy. While evidence for use of investigational AID systems during pregnancy is promising, data and guidance are still needed regarding use of commercially available systems during pregnancy. Automated insulin delivery (AID) systems have established benefits in terms of glycemic control, health outcomes, and quality of life and are strongly recommended for people with type 1 diabetes outside of pregnancy.
